Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Isenberg

Showing results (361-370 of 519) with videos related to

Pageof 52
Sort By:
Clinical and Experimental Rheumatology|October 1, 1987
Anti-Rnp antibodies in chronic liver diseasesF Konikoff, Y Shoenfeld, D A Isenberg, et al.
British Journal of Rheumatology|May 1, 1986
Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis?A W Segal, D A Isenberg, V Hajirousou, et al.
British Journal of Haematology|November 1, 1992
Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipidD M Keeling, A J Wilson, I J Mackie, et al.
Journal of Clinical Pathology|July 1, 1993
Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein ID M Keeling, A J Wilson, I J Mackie, et al.
Annals of the Rheumatic Diseases|February 1, 1982
Neutrophil function in systemic lupus erythematosus and other collagen diseasesH Al-Hadithy, D A Isenberg, I E Addison, et al.
The Quarterly Journal of Medicine|January 1, 1982
Useful laboratory measurements in the management of systemic lupus erythematosusW J Morrow, D A Isenberg, A Todd-Pokropek, et al.
Arthritis and Rheumatism|September 1, 1988
Studies of a common idiotype PR4 in autoimmune rheumatic diseaseW Williams, A Zumla, R Behrens, et al.
Annals of the Rheumatic Diseases|June 1, 1987
Measurement of anti-DNA antibodies: a reappraisal using five different methodsD A Isenberg, C Dudeney, W Williams, et al.
British Journal of Rheumatology|August 1, 1985
Lupus-like nephritis heralding the definitive manifestation of systemic lupus erythematosusC Fisher, W R Gibb, S L Cohen, et al.
The Journal of Rheumatology|August 1, 1997
Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosusT Stoll, C Gordon, B Seifert, et al.
Pageof 52

Showing results (361-370 of 519) with videos related to

Sort By:
Pageof 52
Clinical and Experimental Rheumatology|October 1, 1987
Anti-Rnp antibodies in chronic liver diseasesF Konikoff, Y Shoenfeld, D A Isenberg, et al.
British Journal of Rheumatology|May 1, 1986
Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis?A W Segal, D A Isenberg, V Hajirousou, et al.
British Journal of Haematology|November 1, 1992
Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipidD M Keeling, A J Wilson, I J Mackie, et al.
Journal of Clinical Pathology|July 1, 1993
Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein ID M Keeling, A J Wilson, I J Mackie, et al.
Annals of the Rheumatic Diseases|February 1, 1982
Neutrophil function in systemic lupus erythematosus and other collagen diseasesH Al-Hadithy, D A Isenberg, I E Addison, et al.
The Quarterly Journal of Medicine|January 1, 1982
Useful laboratory measurements in the management of systemic lupus erythematosusW J Morrow, D A Isenberg, A Todd-Pokropek, et al.
Arthritis and Rheumatism|September 1, 1988
Studies of a common idiotype PR4 in autoimmune rheumatic diseaseW Williams, A Zumla, R Behrens, et al.
Annals of the Rheumatic Diseases|June 1, 1987
Measurement of anti-DNA antibodies: a reappraisal using five different methodsD A Isenberg, C Dudeney, W Williams, et al.
British Journal of Rheumatology|August 1, 1985
Lupus-like nephritis heralding the definitive manifestation of systemic lupus erythematosusC Fisher, W R Gibb, S L Cohen, et al.
The Journal of Rheumatology|August 1, 1997
Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosusT Stoll, C Gordon, B Seifert, et al.
Pageof 52